YAP1 and gastric cancer: Along these lines, AnxA6-containing EVs from CAFs also contributed to drug resistance in a peritoneal metastasis mouse model for gastric cancer, possibly via activation of integrin β1, focal adhesion kinase (FAK) and yes-associated protein 1 (YAP) signaling [353].